Income Statement
VERRICA PHARMACEUTICALS INC.
VRCA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
35.58 | 7.57 | 5.12 | 9.03 | 12.00 | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
35.58 | 7.57 | 5.12 | 9.03 | 12.00 | - | - | - |
|
Operating Expenses
|
47.76 | 73.49 | 70.88 | 30.33 | 42.91 | 40.18 | 30.08 | 23.38 |
|
Research & Development
|
8.86 | 11.84 | 20.30 | 12.20 | 15.93 | 15.67 | 15.44 | 12.94 |
|
Selling, General & Administrative
|
35.22 | 58.82 | 47.31 | 17.41 | 26.98 | 24.51 | 14.64 | 10.44 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-12.19 | -65.92 | -65.76 | -21.30 | -30.91 | -40.18 | -30.08 | -23.38 |
|
Non-Operating Income
|
-5.70 | -10.66 | -1.24 | -3.19 | -4.17 | -2.51 | 1.87 | 1.23 |
|
Interest Income
|
0.93 | 1.42 | 2.74 | 0.48 | 0.12 | 0.52 | 1.88 | 1.23 |
|
Interest Expense
|
7.50 | - | 4.00 | 2.20 | 4.30 | 3.03 | - | - |
|
Other Non-Op Income / Expense
|
0.00 | -0.02 | -0.01 | -0.06 | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-17.89 | -76.58 | -67.00 | -24.49 | -35.08 | -42.69 | -28.21 | -20.65 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-12.19 | -65.92 | -65.76 | -21.30 | -30.91 | -40.18 | -30.08 | -23.38 |
|
Earnings Per Share (Basic)
|
-1.68 | -1.48 | -1.48 | -0.72 | - | - | - | - |
|
Diluted EPS
|
-1.68 | -1.48 | -1.48 | -0.72 | - | - | - | - |
|
Weighted Average Shares
|
10.65 | 51.81 | 45.34 | 34.16 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
10.65 | 51.81 | 45.34 | 34.16 | - | - | - | - |
|
Comprehensive Income
|
- | - | -67.00 | -24.46 | -35.11 | -42.71 | -28.17 | 1.50 |